Medical Devices Businesses for Sale

The company is located in São Paulo, Brazil and is an authorized Class III and IV medical products manufacturer. - Offering a wide range of high-complexity medical devices and equipment. - The product range includes monitoring devices, suture and sealing materials, advanced therapy products such as cell and gene therapies and implantable drug delivery devices, perfusion systems for transplants, biocompatibility materials for bone grafts, regenerative barrier membranes, and hydrogels for medical applications. - Additionally, the company manufactures surgical implants including orthopedic prosthetics, vascular stents, plates and screws for bone fixation, monitoring devices like pacemakers, implantable glucose monitors, and neurostimulator devices, as well as diagnostic equipment such as imaging equipment, blood analysis systems, and biopsy equipment. - The company can benefit from various government laws and support programs in Brazil, including tax incentives, REIDI, ICMS incentives, and financing and credit programs. - The authorization by ANVISA in accordance with RDC No. 665 opens up numerous marketing opportunities for the company, allowing it to meet the needs of a constantly growing market in the healthcare sector.

Business exporting medical devices to 4 continents. - We have limited fixed costs. - The business has tied up with a 3rd party manufacturer from Italy for the manufacturing of its products. - We have 2 patents, one from the US and the other from WIPO. - Trade Mark for our brand has also been obtained. - The business has clients around the GCC from Qatar, Saudi, Italy, Sweden, Turkey, Norway, and Brazil. We have 7+ active clients. - We directly sell to distributors. - The owner works from Italy out of their home office, the legal entity has been registered in the USA for tax benefits. The physical presence of the owner in the office is not required for the business to work efficiently, we have matured as a company. - We hire part-time employees when required for our operations. - Business has a very low cost of sales and a consistent gross profit margin of 80%

Our company has built a proprietary technology that instantly stops bleeding for stabbing wounds, gunshot wounds or any other deep wounds using our 3 times patented process. - We have 3 granted worldwide patents along with 3 trademarks on our technology. - Our company has built two products using our technology and have recently completed building the prototypes. The products are essentially self-help kits that minimise blood leakage. - Our company has tested our concept, technology and products using clinical trials at various medical universities in Germany. We are currently in the midst of receiving FDA approval for our products. - Our company has not generated any revenue as we haven't begun commercial production, penetrated the market or even licensed the technology. - This transaction includes the entire business entity, rights and ownership of the patents, trademarks and technology along with all the physical assets. Potential buyer can steer the company as per their respective vision.

Company was started 12 years ago and has been engaged in medical devices (A-PRP kit) development for 6 years now. - The company owns the technology, and is involved in the distribution of the highly demanding product (medical device) called A-PRP kit (the name stands for Autologous Platelet Rich Plasma) - These kits are widely used in many fields of medicine starting from orthopedics, aesthetic medicine, plastic surgery, sports medicine, rheumatology, dermatology, and many others. - The kits are unified and prepared for sale across the whole world. All parts of the A-PRP kit comes from Europe (Germany, Italy, Poland) - Products are manufactured by a notified, authorized factory in Poland to which production is outsourced. - The product is backed by all necessary certificates enabling it to manufacture and distribute on the territory of Europe. - The main clients are hospitals, private practitioners, doctors, beauty clinics, sports clinics, etc.

Company specializing in developing heart prosthesis. - Have already developed 1 prosthesis and further developing 5 prostheses models. - Our company has the FDA certification to develop 8,000 commercialized prostheses by this year in the USA. - Have patent deposit at European Patent Office in Munich, Germany. - We have, at this moment, 20 international cardiovascular groups from Brasil, Argentina, Peru, USA, Europa and South Africa interested in implanting this new prosthesis. - We are one of the well-known developers in this space. - Approx. manufacturing price of each prosthesis is USD 1,000 and selling price is USD 20,000. - Products can be manufactured by certified contract manufacturers locally.

Company in Illinois specializes in incubating innovative technology companies in the field of health and wellness with an emphasis on applications of artificial intelligence and patient centricity. The owner of the business has over 16 years of experience in healthcare technology and hi-tech space, especially with building IoT, cloud, and AI software solutions. The team has created remote monitoring solutions for cardiac monitoring of rhythms, arrhythmias, and EKG telemetry. The platform comes with a mobile app that connects to a single-channel ECG device via Bluetooth BLE and processes it for real-time ECG streaming, ECG videos, cardiac reporting, and storing the data to the cloud. The platform currently supports two devices: An FDA cleared single channel EKG patch and a CE grade single channel EKG device. Note that the company does not manufacture devices. The platform was designed to integrate with multiple devices. ECG is clinical quality and the software has already been used in multiple research projects. Software for remote monitoring and telemetry can be brought to market quickly. Note that this platform can be sold globally through CE and FDA cleared devices. Customer segments would be cardiac patients, cardiologists, hospitals, assisted living centers, research labs, or pharma companies. Specific use cases include continuous cardiac monitoring, post-procedure arrhythmia monitoring, sleep studies, and clinical research. Revenue would be generated from paid services and device sales. CPT codes for reimbursements available on request (for the US only). The business does not have any physical assets. Ideally, the seller would like to license the software platform to the buyer. He is open to discussing alternatives such as partnership contracts, asset-sale, etc. In the case of an acquisition, the buyer would get the mobile app, iOS and Android source code, iOS and Android SDKs, developers portal, cloud platform, test devices, list of suppliers, and all versions of the software code with version control.

3 decade old non-operational medical device shell company in New York. - This established business had operated in the medical device and healthcare services sector for many years. - We used to manufacture and distribute medical, dental, and industrial X-Ray film processors but the new buyer can take the business in other verticals if needed. - The operating entities have been sold already but the public entity with $18mm in tax offsets, experienced board leadership with access to capital and excellent track record make this an ideal opportunity for a reverse merger. - The company was listed in New York Stock Exchange. - Buyer would get the company with tax offset benefits, experienced board members.

An ophthalmology product manufacturer that started operations in 2010. - The product is used to help individuals with eyesight problems to see better. - The products are manufactured by a third party manufacturer in Russia. - We sell our products through Amazon, eBay, Alibaba and directly to customers. - We have been voted the top-40 best inventions of the world according to Plug and Play, China and Top-100 best inventions according to the patent office.